MedTrace Logo

Effects of Kinesio Taping in Addition to Routine Physical Therapy on Pain, Range of Motion and Functional Disability in Patients With Upper Cross Syndrome

NCT05191043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-02-08

No results posted yet for this study

Summary

Objective of the study is to compare the effects of kinesio taping and routine physical therapy on pain, range of motion and functional disability in patients with upper cross syndrome.It is a single blinded randomized controlled trial using non probability purposive sampling technique.

ALTERNATIVE HYPOTHESIS:

There is a significant difference in the effects of routine physical therapy with and without kinesio taping on pain, range of motion and functional disability in patients with upper cross syndrome.

NULL HYPOTHESIS:

There is no significant difference in the effects of routine physical therapy with and without kinesio taping on pain, range of motion and functional disability in patients with upper cross syndrome.

Conditions

  • Cervical Pain

Interventions

OTHER

Kinesio Taping Technique

Kinesio taping is a thin, stretchy, elastic cotton strip with an acrylic adhesive that is approximately the same thickness as the epidermis of the skin. When the taping method is followed correctly, the tape effects on the muscle by facilitating a weakened muscle or relaxing an over-used muscle,decreasing pain, fatigue and increasing tissue recovery. Kinesio Taping facilitation technique will be used with fifty percent stretch on rhomboids bilaterally.

OTHER

Routine Physical Therapy

routine physical therapy includes thermotherapy and Transcutaneous electrical nerve stimulation (TENS), the strengthening exercises of lower and middle trapezius, rhomboids and deep neck flexors. Stretching exercises of upper trapezius, pectoralis major and minor. Mobilization of cervicothoracic junction and postural education. Thermotherapy and transcutaneous electrical nerve stimulation will be used for 10 minutes in each session. Each exercise will be performed in 3 sets of 10 repetitions. Treatment session will have a duration of 30-45 minutes.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Principal Investigators

  • Sobia Ghafoor, MSPT · University of Lahore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2022-02-05
Completion
2022-02-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191043 on ClinicalTrials.gov